Cargando...
New prognostic biomarkers and therapeutic effect of bevacizumab for patients with non-small-cell lung cancer
BACKGROUND: Several biomarkers have emerged as potential prognostic and predictive markers for non-small-cell lung cancer (NSCLC). Successful inhibition of angiogenesis with the antivascular endothelial growth factor antibody, bevacizumab, has improved the efficacy seen with standard cytotoxic thera...
Gardado en:
| Publicado en: | Lung Cancer (Auckl) |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Dove Medical Press
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5546813/ https://ncbi.nlm.nih.gov/pubmed/28814907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S138887 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|